A detailed history of Martin & CO Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Martin & CO Inc holds 15,945 shares of MRK stock, worth $1.97 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
15,945
Previous 16,434 2.98%
Holding current value
$1.97 Million
Previous $1.79 Million 17.42%
% of portfolio
0.54%
Previous 0.46%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $55,374 - $64,523
-489 Reduced 2.98%
15,945 $2.1 Million
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $131,736 - $143,361
-1,315 Reduced 7.41%
16,434 $1.79 Million
Q3 2023

Nov 02, 2023

BUY
$102.95 - $114.33 $90,801 - $100,839
882 Added 5.23%
17,749 $1.83 Million
Q2 2023

Aug 10, 2023

SELL
$108.61 - $118.38 $82,760 - $90,205
-762 Reduced 4.32%
16,867 $1.95 Million
Q1 2023

May 09, 2023

SELL
$102.94 - $114.86 $50,955 - $56,855
-495 Reduced 2.73%
17,629 $1.88 Million
Q4 2022

Feb 03, 2023

BUY
$87.44 - $112.11 $40,921 - $52,467
468 Added 2.65%
18,124 $2.01 Million
Q3 2022

Oct 26, 2022

BUY
$84.53 - $94.96 $22,400 - $25,164
265 Added 1.52%
17,656 $1.52 Million
Q2 2022

Aug 11, 2022

BUY
$83.49 - $94.64 $16,864 - $19,117
202 Added 1.18%
17,391 $1.59 Million
Q1 2022

May 04, 2022

SELL
$73.51 - $82.4 $83,580 - $93,688
-1,137 Reduced 6.2%
17,189 $1.41 Million
Q4 2021

Feb 01, 2022

SELL
$72.28 - $90.54 $2,457 - $3,078
-34 Reduced 0.19%
18,326 $1.41 Million
Q3 2021

Nov 02, 2021

BUY
$71.68 - $78.83 $103,577 - $113,909
1,445 Added 8.54%
18,360 $1.38 Million
Q2 2021

Jul 28, 2021

SELL
$70.31 - $77.77 $59,130 - $65,404
-841 Reduced 4.74%
16,915 $1.32 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $19,900 - $23,440
-289 Reduced 1.6%
17,756 $1.37 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $5,382 - $5,973
75 Added 0.42%
18,045 $1.48 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $24,149 - $27,373
330 Added 1.87%
17,970 $1.49 Million
Q2 2020

Aug 19, 2020

BUY
$70.42 - $80.13 $5,140 - $5,849
73 Added 0.42%
17,640 $1.36 Million
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $12,165 - $16,861
192 Added 1.11%
17,567 $1.35 Million
Q4 2019

Feb 13, 2020

BUY
$77.58 - $87.54 $31,032 - $35,016
400 Added 2.36%
17,375 $1.58 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $5,706 - $6,219
-75 Reduced 0.44%
16,975 $1.43 Million
Q2 2019

Aug 15, 2019

SELL
$69.84 - $81.59 $29,123 - $34,023
-417 Reduced 2.39%
17,050 $1.43 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $8,001 - $9,126
-115 Reduced 0.65%
17,467 $1.45 Million
Q4 2018

Feb 13, 2019

SELL
$65.24 - $75.71 $8,154 - $9,463
-125 Reduced 0.71%
17,582 $1.34 Million
Q3 2018

Nov 15, 2018

SELL
$57.69 - $67.84 $30,575 - $35,955
-530 Reduced 2.91%
17,707 $1.26 Million
Q2 2018

Aug 15, 2018

SELL
$50.83 - $59.72 $1,626 - $1,911
-32 Reduced 0.18%
18,237 $1.11 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $1.78 Million - $2.07 Million
-34,998 Reduced 65.7%
18,269 $995,000
Q4 2017

Feb 15, 2018

BUY
$51.62 - $61.64 $6,710 - $8,013
130 Added 0.24%
53,267 $3 Million
Q3 2017

Nov 15, 2017

SELL
$58.67 - $63.13 $336,179 - $361,734
-5,730 Reduced 9.73%
53,137 $3.4 Million
Q2 2017

Aug 15, 2017

BUY
N/A
58,867
58,867 $3.77 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $314B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Martin & CO Inc Portfolio

Follow Martin & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Martin & CO Inc with notifications on news.